Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer

Cancer ◽

10.1002/cncr.29636 ◽

2015 ◽

Vol 121 (23) ◽

pp. 4165-4172 ◽

Author(s):

Lakshmi Nayak ◽

Lisa M. DeAngelis ◽

H. Ian Robins ◽

Ramaswamy Govindan ◽

Shirish Gadgeel ◽

...

Keyword(s):

Lung Cancer ◽

Brain Metastases ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase 2 ◽

Small Cell Lung ◽

Multicenter Phase ◽

Download Full-text

Early whole brain concomitant radiotherapy-chemotherapy for non-small cell lung cancer (NSCLC) brain metastases. A phase 2 study

Lung Cancer ◽

10.1016/s0169-5002(00)80330-x ◽

2000 ◽

Vol 29 (1) ◽

pp. 100-101

Author(s):

C Ngo Quy ◽

M.-A Haller ◽

A Darut-Jouve ◽

G Jolimoy ◽

D Spaëth ◽

...

Keyword(s):

Lung Cancer ◽

Brain Metastases ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase 2 ◽

Small Cell Lung ◽

Whole Brain ◽

Phase 2 Study ◽

Concomitant Radiotherapy

Download Full-text

Phase 2 study of ceritinib in ALKi-naïve patients (pts) with ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC): Whole body responses in the overall pt group and in pts with baseline brain metastases (BM)

Annals of Oncology ◽

10.1093/annonc/mdw383.03 ◽

2016 ◽

Vol 27 ◽

pp. vi416 ◽

Author(s):

E. Felip ◽

S. Orlov ◽

K. Park ◽

C.-J. Yu ◽

C.-M. Tsai ◽

...

Keyword(s):

Lung Cancer ◽

Brain Metastases ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase 2 ◽

Small Cell Lung ◽

Download Full-text

Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin for chemotherapy-naive patients with extensive-disease small cell lung cancer

Cancer ◽

10.1002/cncr.24719 ◽

2009 ◽

pp. NA-NA

Author(s):

Dae Ho Lee ◽

Sang-We Kim ◽

Cheolwon Suh ◽

Jung-Shin Lee ◽

Jin Seok Ahn ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase 2 ◽

Small Cell Lung ◽

Extensive Disease ◽

Multicenter Phase ◽

Download Full-text

Faculty Opinions recommendation of Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969276.793473915 ◽

2013 ◽

Author(s):

Sam Janes ◽

Laura Succony

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase 2 ◽

Small Cell Lung ◽

Download Full-text

Faculty Opinions recommendation of Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969276.793468807 ◽

2013 ◽

Author(s):

Thomas Stinchcombe

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase 2 ◽

Small Cell Lung ◽

Download Full-text

P82.02 Stereotactic Ablative Radiotherapy with Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer: a phase 2 study

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.1193 ◽

2021 ◽

Vol 16 (3) ◽

pp. S651-S652

Author(s):

J. Beal ◽

D. Gomes ◽

P. Taranto ◽

L. Koch ◽

A.C. Rezende ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Early Stage ◽

Stereotactic Ablative Radiotherapy ◽

Phase 2 ◽

Small Cell Lung ◽

Download Full-text

Anlotinib vs placebo as third- or further-line treatment for patients with small cell lung cancer: a randomised, double-blind, placebo-controlled Phase 2 study

British Journal of Cancer ◽

10.1038/s41416-021-01356-3 ◽

2021 ◽

Author(s):

Ying Cheng ◽

Qiming Wang ◽

Kai Li ◽

Jianhua Shi ◽

Ying Liu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Line Treatment ◽

Phase 2 ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

P2.01-19 Phase 2 Study of Telisotuzumab Vedotin (Teliso-V) in Previously Treated c-MET+ Non-Small Cell Lung Cancer: Trial in Progress

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1363 ◽

2019 ◽

Vol 14 (10) ◽

pp. S646 ◽

Author(s):

C. Ocampo ◽

J. Wu ◽

J. Dey ◽

Z. Sun ◽

M. Motwani ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase 2 ◽

Small Cell Lung ◽

Cancer Trial ◽

Phase 2 Study ◽

Previously Treated

Download Full-text

Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2011.09.006 ◽

2012 ◽

Vol 76 (1) ◽

pp. 78-83 ◽

Author(s):

Benjamin Besse ◽

David Planchard ◽

Anne-Sophie Veillard ◽

Laurent Taillade ◽

David Khayat ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase 2 ◽

Small Cell Lung ◽

Download Full-text

A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.07.2260 ◽

2015 ◽

Vol 93 (4) ◽

pp. 757-764 ◽

Author(s):

Gregory M.M. Videtic ◽

Chen Hu ◽

Anurag K. Singh ◽

Joe Y. Chang ◽

William Parker ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Stereotactic Body Radiation Therapy ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text